Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1591 AL 1605

Cross-sectional and prospective associations between homocysteine and a frailty index: A post-hoc analysis of the multidomain Alzheimer's prevention trial (MAPT)

St-Martin P, Dionne IJ, Maltais M, Rolland Y; MAPT/DSA Study Group.

Exp Gerontol. 2023 Feb;172:112066. doi: 10.1016/j.exger.2022.112066. Epub 2022 Dec 20.

Sulfotransferase 2B1b, Sterol Sulfonation, and Disease

Cook I, Leyh TS.

Pharmacol Rev. 2023 May;75(3):521-531. doi: 10.1124/pharmrev.122.000679. Epub 2022 Dec 22.

Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders

Kaur P, Khera A, Alajangi HK, Sharma A, Jaiswal PK, Singh G, Barnwal RP.

Mol Neurobiol. 2023 Mar;60(3):1690-1720. doi: 10.1007/s12035-022-03164-z. Epub 2022 Dec 23.

Neuroimmune mechanisms underlying Alzheimer's disease: Insights into central and peripheral immune cell crosstalk

Liu Y, Tan Y, Zhang Z, Li H, Yi M, Zhang Z, Hui S, Peng W.

Ageing Res Rev. 2023 Feb;84:101831. doi: 10.1016/j.arr.2022.101831. Epub 2022 Dec 21.

Insulin resistance in Alzheimer's disease: The genetics and metabolomics links

Amin AM, Mostafa H, Khojah HMJ.

Clin Chim Acta. 2023 Jan 15;539:215-236. doi: 10.1016/j.cca.2022.12.016. Epub 2022 Dec 22.

The role of adenosine A(2A) receptors in Alzheimer's disease and tauopathies

Launay A, Nebie O, Vijaya Shankara J, Lebouvier T, Buée L, Faivre E, Blum D.

Neuropharmacology. 2023 Mar 15;226:109379. doi: 10.1016/j.neuropharm.2022.109379. Epub 2022 Dec 23.

Does Multicomponent Physical Exercise Training Work for Dementia? Exploring the Effects on Cognition, Neuropsychiatric Symptoms, and Quality of Life

Borges-Machado F, Teixeira L, Carvalho J, Ribeiro O.

J Geriatr Psychiatry Neurol. 2023 Sep;36(5):376-385. doi: 10.1177/08919887221149152. Epub 2022 Dec 27.

Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer's disease: an insight into structure-activity relationship

Halder D, Das S, R S J, Joseph A.

J Biomol Struct Dyn. 2023 Dec;41(20):11286-11323. doi: 10.1080/07391102.2022.2158136. Epub 2022 Dec 29.

Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies

Imbimbo BP, Ippati S, Watling M, Imbimbo C.

Pharmacol Res. 2023 Jan;187:106631. doi: 10.1016/j.phrs.2022.106631. Epub 2022 Dec 28.

Noradrenergic therapies for apathy in Alzheimer's disease?

Husain M.

J Neurol Neurosurg Psychiatry. 2023 Feb;94(2):93. doi: 10.1136/jnnp-2022-330824. Epub 2022 Dec 5.

The kynurenine pathway in Alzheimer's disease: a meta-analysis of central and peripheral levels

Fernandes BS, Inam ME, Enduru N, Quevedo J, Zhao Z.

Braz J Psychiatry. 2023 May-Jun;45(3):286-297. doi: 10.47626/1516-4446-2022-2962. Epub 2022 Feb 8.

Testing the knowledge of Alzheimer's disease via an intervention study among community health service center staff in Jiaxing, China

Ma W, Zhu L, Tang J, Diao W, Qian L, Feng X, Zhang X.

Front Public Health. 2023 Jan 27;10:969653. doi: 10.3389/fpubh.2022.969653. eCollection 2022.

Did the COVID-19 Pandemic Affect the Use of Antipsychotics Among Nursing Home Residents With ADRD?

Yan D, Temkin-Greener H, Cai S.

Am J Geriatr Psychiatry. 2023 Feb;31(2):124-140. doi: 10.1016/j.jagp.2022.09.009. Epub 2022 Sep 28.

Risk of Subsequent Dementia or Alzheimer Disease Among Patients With Age-Related Macular Degeneration: A Systematic Review and Meta-analysis

Tsai HR, Lo RY, Liang KH, Chen TL, Huang HK, Wang JH, Lee YC.

Am J Ophthalmol. 2023 Mar;247:161-169. doi: 10.1016/j.ajo.2022.11.005. Epub 2022 Nov 12.

The Costs of Dementia in Europe: An Updated Review and Meta-analysis

Jönsson L, Tate A, Frisell O, Wimo A.

Pharmacoeconomics. 2023 Jan;41(1):59-75. doi: 10.1007/s40273-022-01212-z. Epub 2022 Nov 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias